Documents A Phase I Study of MK-2206, an Oral Potent Allosteric Akt Inhibitor in Patients with Advanced Solid....

Slide 1A Phase I Study of MK-2206, an Oral Potent Allosteric Akt Inhibitor in Patients with Advanced Solid Tumors Anthony W. Tolcher, 1 Timothy A. Yap, 2 Ivy Fearen, 3 Adekemi…

Documents Guideline useofantimicrobialagentsinneutropenicpatients

1.IDSA GUIDELINES Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America…

Health & Medicine Neutropenia febril

1.I D S A G U I D E L I N E SClinical Practice Guideline for the Use ofAntimicrobial Agents in Neutropenic Patientswith Cancer: 2010 Update by the InfectiousDiseases Society…